Suscribirse

Side branch embolization before endovascular abdominal aortic aneurysm repair to prevent type II endoleak: A prospective multicenter study - 01/09/24

Doi : 10.1016/j.diii.2024.03.003 
Tomoyuki Gentsu a, Masato Yamaguchi a, , Koji Sasaki a, Ryota Kawasaki b, Hiroki Horinouchi c, Tetsuya Fukuda c, Naokazu Miyamoto d, Takeki Mori e, Noriaki Sakamoto f, Kensuke Uotani g, Takanori Taniguchi h, Yojiro Koda i, Katsuhiro Yamanaka i, Hiroaki Takahashi i, Kenji Okada i, Taro Hayashi j, Toshitaka Watanabe j, Yoshikatsu Nomura k, Keigo Matsushiro a, Eisuke Ueshima a, Takuya Okada a, Koji Sugimoto a, Takamichi Murakami a
a Department of Diagnostic and Interventional Radiology, Kobe University Hospital, Kobe, 7-5-2 Kusunokicho, Chuo Ward, Kobe City, Hyogo 650-0017, Japan 
b Department of Diagnostic and Interventional Radiology, Hyogo Prefectural Harima-Himeji General Medical Center, Himeji, Hyogo 670-8560, Japan 
c Department of Radiology, National Cerebral and Cardiovascular Center, Suita, Osaka 565-8565, Japan 
d Department of Radiology, Kita-harima Medical Center, Ono, Hyogo 675-1323, Japan 
e Department of Radiology, Japanese Red Cross Kobe Hospital, Kobe, Hyogo 651-0073, Japan 
f Department of Diagnostic and Interventional Radiology, Kakogawa Central City Hospital, Kakogawa, Hyogo 675-8520, Japan 
g Department of Radiology, Hyogo Prefectural Awaji Medical Center, Sumoto, Hyogo 656-0021, Japan 
h Department of Radiology, Tenri Hospital, Tenri, Nara 632-8552, Japan 
i Division of Cardiovascular Surgery, Department of Surgery, Kobe University Hospital, Kobe, Hyogo 650-0017, Japan 
j Department of Cardiovascular Surgery, Akashi Medical Center, Akashi, Hyogo 673-0896, Japan 
k Department of Cardiovascular Surgery, Hyogo Prefectural Harima-Himeji General Medical Center, Himeji, Hyogo 670-8560, Japan 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Highlights

Pre-emptive transcatheter arterial embolization of aortic side branches helps prevent type II endoleak after six months in patients with abdominal aortic aneurysm treated with endovascular abdominal aneurysm repair.
Successful coil embolization is achieved in 80.9% of aortic side branches.
Pre-emptive transcatheter arterial embolization of aortic side branch leads to significant sac shrinkage after 12 months following endovascular abdominal aneurysm repair.

El texto completo de este artículo está disponible en PDF.

Abstract

Purpose

The purpose of the study was to evaluate the efficacy and safety of pre-emptive transcatheter arterial embolization (P-TAE) of aortic side branches to prevent type II endoleak in patients with abdominal aortic aneurysm after endovascular abdominal aneurysm repair (EVAR).

Materials and methods

This multicenter, prospective, single-arm trial enrolled 100 patients with abdominal aortic aneurysm from nine hospitals between 2018 and 2021. There were 85 men and 15 women, with a mean age of 79.6 ± 6.0 (standard deviation) years (range: 65–97 years). P-TAE was attempted for patent aortic side branches, including the inferior mesenteric artery, lumbar arteries, and other branches. The primary endpoint was late type II endoleak incidence at 6 months post-repair. Secondary endpoints included changes in aneurysmal sac diameter at 6- and 12 months, complications, re-intervention, and aneurysm-related mortality. Aneurysm sac changes at 6- and 12 months was compared between the late and no-late type II endoleak groups.

Results

Coil embolization was successful in 80.9% (321/397) of patent aortic side branches, including 86.3% of the inferior mesenteric arteries, 80.3% of lumbar arteries, and 55.6% of other branches without severe adverse events. Late type II endoleak incidence at 6 months was 8.9% (8/90; 95% confidence interval: 3.9–16.8%). Aneurysm sac shrinkage > 5 mm was observed in 41.1% (37/90) and 55.3% (47/85) of the patients at 6- and 12-months post-EVAR, respectively. Patients with late type II endoleak had less aneurysm sac shrinkage than those without type II endoleak at 12 months (˗0.2 mm vs. ˗6.0 mm; P = 0.040). No patients required re-intervention for type II endoleak, and no aneurysm-related mortalities occurred.

Conclusion

P-TAE is safe and effective in preventing type II endoleak, leading to early sac shrinkage at 12 months following EVAR.

El texto completo de este artículo está disponible en PDF.

Keywords : Abdominal aortic aneurysm, embolization, Endoleak, Endovascular aneurysm repair, Interventional radiology, Safety

Abbreviations : AAA, ASB, ASC, EVAR, CECT, CI, IMA, LA, PC-AKI, P-TAE, SD, T2EL


Esquema


© 2024  Société française de radiologie. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 105 - N° 9

P. 326-335 - septembre 2024 Regresar al número
Artículo precedente Artículo precedente
  • Percutaneous cryoablation of abdominal wall endometriosis: An analysis of 38 patients
  • Rafy Bachour, Nithida Sengmanivong, Fabien Vidal, Céline Goumarre, Franck Lapègue, Louise Destombes, Hélène Chiavassa Gandois, Yann Tanguy Le Gac, Elodie Chantalat, Jérome Capdet, Donatien Blais, Adrien Guenego, Nicolas Sans, Marie Faruch Bilfeld
| Artículo siguiente Artículo siguiente
  • Prevalence of major embolic findings and incidental findings on early cardiac CT in patients with suspected ischemic stroke
  • Diane Philippe, Angélique Bernard, Frédéric Ricolfi, Yannick Béjot, Gauthier Duloquin, Pierre-Olivier Comby, Charles Guenancia

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.